Med journals adopt disclosure rules

Written byBob Grant

| 2 min read

Editors at leading medical journals have linkurl:agreed;http://www.icmje.org/format.pdf to adopt a new standard conflict of interest disclosure form that probes deep into the financial and nonfinancial interests of published authors. __The Lancet__, __The Journal of the American Medical Association__, __The New England Journal of Medicine__, and __The British Medical Journal__, among other medical journals, will be phasing in the more rigorous requirements over the next couple of months, according to linkurl:__The Wall Street Journal__.;http://online.wsj.com/article/SB125547553843083589.html?mod=dist_smartbrief The disclosure linkurl:form,;http://www.icmje.org/coi_disclosure.pdf which was drafted by the International Committee of Medical Journal Editors (ICMJE), prompts authors for information regarding financial relationships -- such as board membership, consultancy, expert testimony, honoraria and stock options -- and potentially conflicting financial relationships among spouses and children under age 18. Authors are asked to submit financial disclosures for arrangements stretching back up to three years prior to the submission of a manuscript. The form also asks for information regarding "relevant nonfinancial associations," such as political, personal, institutional, or religious affiliations that "a reasonable reader would want to know about in relation to the submitted work." The move follows increasing calls for medical journals to standardize their conflict disclosure policies. Last summer, the Center for Science in the Public Interest (CSPI) unveiled disclosure guidelines that closely parallel the rules set forth by the ICMJE. linkurl:Merrill Goozner,;http://www.gooznews.com/ former director of the CSPI's Integrity in Science project and lead author on that organization's disclosure guidelines, told __The Scientist__ that the ICMJE's rules are welcome, if not overdue. "We feel like our work set the stage for what the ICMJE came out with yesterday," he said. "We helped plant the idea that this is the proper thing to do. We're very glad they did it." Regarding the disclosure of nonfinancial conflicts, such as political or religious affiliations, Goozner noted that the disclosure is between author and editors. "There's obviously room for discretion on the part of the editor as far as what gets published," he said. "I think that's the right thing to do." The ICMJE's new disclosure guidelines apply only to authors, not peer reviewers or editors. Goozner suggested that this is a shortcoming in the new rules. "This is something editors need to know so they can discriminate among who they ask to conduct peer review," he said.
**__Related stories:__***linkurl:Unifying journal disclosure rules;http://www.the-scientist.com/blog/display/54836/
[17th July 2008]*linkurl:Promoting Integrity in Science Journals;http://www.the-scientist.com/article/display/38023/
[January 2007]

Meet the Author

Bob Grant

From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

View Full Profile

Med journals adopt disclosure rules

The Scientist ARCHIVES

Become a Member of

Meet the Author

Bob Grant

Related Research Resources

What Is the Amniotic Fluid Composed of?

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

Advancing Drug Discovery with Complex Human In Vitro Models

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Maximizing Cancer Research Model Systems

Products

Product News

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies